| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Third National Report on the implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
109111
Status
Published
Date of creation
2015-10-30 15:13 UTC (andrew.bowers@cbd.int)
Date of last update
2015-11-02 15:12 UTC (andrew.bowers@cbd.int)
Date of publication
2015-11-02 15:13 UTC (andrew.bowers@cbd.int)

This document is also available in the following languages:
Origin of report
1. Country
  • Kazakhstan
Contact officer for report
Coordinates
Раманкулов Ерлан Мирхайдарович
Национальный координатор по МПБ
Национальный центр биотехнологии Комитета науки Министерства образования и науки Республики Казахстан
13/5 Кургальжинское шоссе
г.Астана
Kazakhstan, 010000
Phone:+7 (7172) 707565
Fax:+7 (7172) 707564
Email:info@biocenter.kz
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
RU
Министерство сельского хозяйства РК, Министерство энергетики РК, Министерство здравоохранения и социального развития РК, Министерство национальной экономики РК, Комитет таможенного контроля Министерства финансов РК, Национальный центр биотехнологии Комитета науки Министерства образования и науки РК, Программа развития ООН
Submission
10. Date of submission
2015-10-30
11. Time period covered by this report
Start date
2011-11-29
11. Time period covered by this report
End date
2015-10-27
Party to the Cartagena Protocol on Biosafety
Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
14. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
This question is relevant to indicators 1.1.1, 2.1.1, 2.1.2, and 3.1.2 of the Strategic Plan
  • A domestic regulatory framework is partially in place
15. If you indicated that a national biosafety framework exists in the above question, when did it become operational?
This question is relevant to the indicator 1.1.1 of the Strategic Plan
  • 2008
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more national biosafety regulations
  • One or more sets of biosafety guidelines
  • Other laws, regulations or guidelines that indirectly apply to biosafety
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • No
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • No
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Partially
21. Here you may provide further details on the implementation of Article 2 in your country
RU
Закон РК «О ратификации Картахенского протокола по биобезопасности  к Конвенции о биологическом разнообразии» (2008).
Постановлением Правительства РК "О мерах по обеспечению выполнения Республикой Казахстан обязательств, вытекающих из Картахенского протокола по биобезопасности к Конвенции о биологическом разнообразии" №1282 от 26 декабря 2008 года, Министерство сельского хозяйства РК назначено национальным координационным центром по Картахенскому протоколу по биобезопасности (КПБ), Министерство науки и образования РК - компетентным национальным органом.   
Закон  РК «О безопасности пищевой продукции» (2008), Кодекс РК «О здоровье населения и системе здравоохранения» (2009), «Технический регламент Таможенного союза 021/2011 "О безопасности пищевой продукции", утвержденный решением Комиссии таможенного союза от 9 декабря 2011 года № 880 и технический регламент Таможенного союза «Пищевая продукция в части маркировки», утвержденного Решением Комиссии Таможенного союза от 9 декабря 2011 года № 881», регламентируют государственный контроль безопасности пищевой продукции, маркировки и регистрации ГМО.
Экологический Кодекс РК (2009) регламентирует экологические требования при производстве и использовании потенциально опасных химических и биологических веществ, ГМ продуктов и организмов.
Закон  РК «О защите прав потребителей» (2010), обязывает производителей маркировать продукцию, если она  содержит 0,9 и более процентов ГМО.
Закон Республики Казахстан « О семеноводстве» (2003) регламентирует ввоз и высев семян сортов растений, полученных на основе генной инженерии.
Разработан проект Закона РК «О государственном регулировании генно-инженерной деятельности», который находится на рассмотрении в Мажилисе Парламента РК.
Постановлением Правительства РК от 27 июня 2008 года № 630 утверждены Правила оборота генетически модифицированных объектов на территории Республики Казахстан. Согласно правил, оборот генетически модифицированных объектов допускается только после научно обоснованного подтверждения их безопасности, и проведения их государственной регистрации.
Постановлением Правительства РК от 16 апреля 2008 г. № 346 утверждены Правила проведения работ по научно обоснованному подтверждению безопасности генетически модифицированных объектов.
Технический регламент «Требования к безопасности пищевой продукции, полученной из генно-модифицированных растений и животных» (2010) и «Требования к упаковке, маркировке, этикетированию и правильному их нанесению» (2008), устанавливают требования к безопасности пищевой продукции, полученной из генно-модифицированных растений и животных при ее разработке, производстве, обороте, утилизации и уничтожении.
Тех. регламент «Требования к упаковке, маркировке, этикетированию и правильному их нанесению» (2008), устанавливает требования к способам расфасовки и упаковки, а также упаковочным материалам, используемым при обороте ГМО.
Стандарты РК по методам идентификации ГМИ растительного происхождения на основе использования ПЦР (СТ РК 1346-2005) и микрочипов (СТ РК 1345-2005).
Article 5 - Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • Yes
23. If you answered Yes to question 22, has this information been submitted to the BCH?
  • Partially
24. Here you may provide further details on the implementation of Article 5 in your country:
RU
Запрещается обращение (ввоз, производство и медицинское использование) на рынке Республики Казахстан лекарственных средств, включая биотехнологических лекарственных препаратов, произведенных путем биотехнологических процессов с применением современных биотехнологий не прошедших государственную регистрацию в Республике Казахстан.  Требования к безопасности, эффективности и качеству биотехнологических препаратов и препаратов биологического происхождения предъявляются при экспертизе лекарственных средств, в рамках государственной регистрации. Государственная регистрация регламентирована Кодексом РК «О здоровье народа и системе здравоохранения» и приказами уполномоченного органа в области здравоохранения (приказы Министерства здравоохранения  РК от 18 ноября 2009 года №735 и от 18 ноября 2009 года №736)
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
This question is relevant to indicator 1.8.1 of the Strategic Plan
  • Yes, to some extent
26. Does your country regulate the contained use of LMOs?
This question is relevant to indicators 1.1.2 and 1.8.2 of the Strategic Plan
  • Yes
27. If you answered Yes to questions 25 or 26, has this information been submitted to the BCH?
  • Partially
28. Here you may provide further details on the implementation of Article 6 in your country:
RU
Статья 6 частично осуществляется в соответствии с постановлениями Правительства РК от 27 июня 2008 года № 630 "Правила оборота генетически модифицированных объектов на территории Республики Казахстан" и от 16 апреля 2008 г. № 346 "Правила проведения работ по научно обоснованному подтверждению безопасности генетически модифицированных объектов".
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol OR a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
This question is relevant to indicators 1.1.2 and 3.1.4 of the Strategic Plan
  • No
30. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
32. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • No
33. Has your country established legal requirements for the accuracy of information contained in the notification?
  • No
34. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
This question is relevant to indicator 1.1.4 of the Strategic Plan
  • No
35. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
This question is relevant to indicator 1.1.5 of the Strategic Plan
  • No
38. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
39. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
46. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment
RU
Осуществление статей 7-10 частично регулируется Экологическим кодексом РК от 9 января 2007 г № 212, в частности ст. 281 "Охрана окружающей среды от вредного и неконтролируемого биологического воздействия" и ст.282 "Порядок осуществления генноинженерной деятельности" и Правилами оборота генетически модифицированных объектов, утвержденными постановлением Правительства РК от 27 июня 2008 г. № 630.
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
47. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
This question is relevant to indicator 1.1.2 of the Strategic Plan
  • Yes
48. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • Yes, to some extent
Here you may provide further details
RU
Технический регламент "Требования к безопасности пищевой продукции, полученной из генно-модифицированных (трансгенных) растений и животных"
49. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
This question is relevant to indicator 3.1.5 of the Strategic Plan
  • No
50. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
This question is relevant to indicator 1.1.2 of the Strategic Plan
  • Yes
51. Has your country indicated its needs for financial and technical assistance and capacity-building in respect of LMOs-FFP?
This question is relevant to indicator 1.2.1 of the Strategic Plan
  • No
52. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
58. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP
RU
Статья 11 частично осуществляется в соответствии с постановлением Правительства РК от 27 июня 2008 года № 630 "Правила оборота генетически модифицированных объектов на территории Республики Казахстан" и Техническим регламентом "Требования к безопасности пищевой продукции, полученной из генно-модифицированных (трансгенных) растений и животных", утвержденным постановлением Правительства РК от 21.09.2010 г. №969.
Article 12 – Review of decision
59. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • No
60. Has your country ever received a request for a review of a decision?
  • No
61. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
62. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
Article 13 – Simplified procedure
67. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
68. Has your country ever applied the simplified procedure?
  • No
70. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
Article 14 – Bilateral, regional and multilateral agreements and arrangements
72. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • Yes
73. If you answered Yes to question 72, how many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
This question is relevant to indicator 1.2.8 of the Strategic Plan
  • None
74. If you answered Yes to question 72, has your country informed the Parties through the BCH of the agreements or arrangements?
This question is relevant to indicator 3.1.5 of the Strategic Plan
  • No
75. If you answered Yes to question 72, please provide a brief description of the scope and objective of the agreements or arrangements entered into
RU
Статья 11 частично осуществляется в соответствии с постановлением Правительства РК от 27 июня 2008 года № 630 "Правила оборота генетически модифицированных объектов на территории Республики Казахстан" и Техническим регламентом "Требования к безопасности пищевой продукции, полученной из генно-модифицированных (трансгенных) растений и животных", утвержденным постановлением Правительства РК от 21.09.2010 г. №969.
76. Here you may provide further details on the implementation of Article 14 in your country
RU
Статья 14 осуществляется в соответствии с Техническими регламентами Таможенного союза от 9 декабря 2011 года: № 880 ТР ТС 021/2011 «О безопасности пищевой продукции», №881 ТР ТС 022/2011 «Пищевая продукция в части ее маркировки», №874 ТР ТС 015/2011 «О безопасности зерна».
Articles 15 & 16 – Risk Assessment and Risk Management
77. Has your country established a national framework for conducting risk assessments prior to taking decisions regarding LMOs?
  • Yes, to some extent
Here you may provide further details
RU
Постановление Правительства РК от 16 апреля 2008 года №346 "Об утверждении Правил проведения работ по научно обоснованному подтверждению безопасности генетически модифицированных объектов"
78. If you answered Yes to question 77, does this framework include procedures for identifying and/or training national experts to conduct risk assessments?
  • Yes
79. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
This question is relevant to indicator 2.2.3 of the Strategic Plan
a) Risk assessment:
  • One or more
b) Management / Control:
  • One or more
c) Monitoring:
  • One or more
80. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • Yes
81. Is your country using the "Manual on Risk Assessment of LMOs" (developed by CBD Secretariat) for training in risk assessment?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • Yes
82. Is your country using the "Guidance on Risk Assessment of LMOs" (developed by the Online Forum and the AHTEG on Risk Assessment and Risk Management) for training in risk assessment?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • Yes
83. Are the currently available training materials or technical guidance on risk assessment and/or risk management of LMOs sufficient?
This question is relevant to indicator 2.2.6 of the Strategic Plan
  • Yes
84. Does your country have the capacity to detect, identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
This question is relevant to indicators 1.4.2 and 1.6.3 of the Strategic Plan
a) Detect:
  • Yes
b) Identify:
  • Yes
c) Assess:
  • No
d) Monitor:
  • No
85. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment or risk management, or for evaluating risk assessment reports submitted by notifiers?
This question is relevant to indicators 1.3.1 of the Strategic Plan
a) Risk assessment:
  • Yes
b) Risk management:
  • No
86. Is your country using the "Guidance on Risk Assessment of LMOs" (developed by the Online Forum and the AHTEG on Risk Assessment and Risk Management) for conducting risk assessment or risk management, or for evaluating risk assessment reports submitted by notifiers?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • Yes
87. Has your country adopted any common approaches to risk assessment with other countries?
This question is relevant to indicator 1.3.2 of the Strategic Plan
  • Yes
88. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
This question is relevant to indicator 1.4.1 of the Strategic Plan
  • No
89. Has your country ever conducted a risk assessment of an LMO including any type of risk assessment of LMOs, e.g. for contained use, field trials, commercial purposes, direct use as food, feed, or for processing?
This question is relevant to indicator 1.3.3 of the Strategic Plan
  • No
94. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • Yes, to some extent
95. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • Yes, to some extent
96. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
This question is relevant to indicator 2.2.4 of the Strategic Plan
  • No
97. Here you may provide further details on the implementation of Articles 15 and 16 in your country
RU
Статьи 15 и 16 частично осуществляются в соответствии с Правилами проведения работ по научно обоснованному подтверждению безопасности генетически модифицированных объектов, утвержденными постановлением Правительства РК от 16 апреля 2008 года №346. В соответствии с правилами оценка риска ГМО на здоровье человека и окружающую среду в Республике Казахстан осуществляется в соответствии с международными стандартами и рекомендациями, другими методическими рекомендациями, в лабораториях и клинических базах, аккредитованных или аттестованных в порядке, установленном законодательством Республики Казахстан. Результаты научно обоснованного подтверждения безопасности ГМО представляются субъектом в уполномоченный орган для регистрации ГМО в порядке, предусмотренном законодательством в области безопасности пищевой продукции. Статьи 15 и 16 частично регулируются Техническим регламентом "Требования к безопасности пищевой продукции, полученной из генно-модифицированных (трансгенных) растений и животных".
Article 17 – Unintentional transboundary movements and emergency measures
98. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • Yes, to some extent
99. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • Yes, to some extent
Here you may provide further details
RU
Назначен Национальный координатор по статье 17 Картахенского протокола
100. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
This question is relevant to indicator 1.8.3 of the Strategic Plan
  • No
101. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
105. Here you may provide further details on the implementation of Article 17 in your country
RU
Осуществление статьи 17 частично регулируется Экологическим кодексом РК от 9 января 2007 г № 212, в частности ст. 281 "Охрана окружающей среды от вредного и неконтролируемого биологического воздействия" и ст.282 "Порядок осуществления генноинженерной деятельности", Законом РК «О безопасности пищевой продукции» (2008), Кодексом РК «О здоровье населения и системе здравоохранения» (2009), Техническим регламентом «Требования к безопасности пищевой продукции, полученной из генно-модифицированных (трансгенных) растений и животных» (2010).
Article 18 – Handling, transport, packaging and identification
106. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • Yes, to some extent
107. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
This question is relevant to indicator 1.6.1 of the Strategic Plan
  • Yes, to some extent
108. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
This question is relevant to indicator 1.6.1 of the Strategic Plan
  • Yes, to some extent
Here you may provide further details
RU
В соответствии пункта 3 статьи 13 «Требования к производству  и использованию семян» Закона Республики Казахстан от 8 февраля 2003 года № 385 «О семеноводстве»: Разрешается высев семян сортов, не включенных в Государственный реестр селекционных достижений, допущенных к использованию в Республике Казахстан, за исключением семян сортов, полученных на основе генной инженерии (генетически модифицированных), в случаях, если: 1) они используются для селекционных и исследовательских работ, а также в целях проведения испытаний в производственных условиях (при наличии положительных результатов испытания сорта сельскохозяйственного растения другими организациями Республики Казахстан или уполномоченных органов других государств) с условием одновременной передачи сорта для проведения государственного сортоиспытания;  2) их размножение предусмотрено международным договором для вывоза за пределы Республики Казахстан.
109. If you answered Yes or Yes, to some extent to question(s) 107 and/or 108, what type of documentation does your country require for the identification of LMOs-FFP?
  • Existing types of documentation
110. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
This question is relevant to indicator 1.6.2 of the Strategic Plan
  • Yes, to some extent
Here you may provide further details
RU
Здесь можно представить дополнительные сведени
111. If you answered Yes or Yes, to some extent to question 110, what type of documentation does your country require for the identification of LMOs that are destined for contained?
  • Existing types of documentation
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
This question is relevant to indicator 1.6.2 of the Strategic Plan
  • Yes, to some extent
113. If you answered Yes or Yes, to some extent to question 112, what type of documentation does your country require for the identification of LMOs that are intended for intentional introduction into the environment?
  • Existing types of documentation
114. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
This question is relevant to indicator 1.6.4 of the Strategic Plan
  • Yes
115. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • Yes, to some extent
116. How many customs officers in your country have received training in the identification of LMOs?
This question is relevant to indicator 2.3.1 of the Strategic Plan
  • None
117. Has your country established procedures for the sampling and detection of LMOs?
  • Yes, to some extent
Here you may provide further details
RU
Технический регламент Таможенного союза «О безопасности пищевой продукции» (ТР ТС 021/2011) от 9 декабря 2011 года № 880; Стандарты РК (СТ РК 1346-2005(Р 52173-2003, MOD) "Биологическая безопасность. Сырье и продукты пищевые. Метод идентификации генетически модифицированных источников (ГМИ) растительного происхождения, СТ РК 1345-2005 (Р 52174-2003, MOD) и микрочипов (СТ РК 1345-2005), методы обнаружения показателей ГМО (скрининга) в соотвествии с международними стандартами (СТ РК ИСО 24276-2010, 21569, 21570, 21571 и Протоколами Референс лаборатории Европейского союза): Промотор P-35S CaMV; Терминатор T-nos Agrobacterium tumefaciens;Ген nptII; Промотор P-35S FMV; Ген Bar Streptomyces hygroscopicus; Ген CP4 epsps Agrobacterium tumefasciens; Ген СryIA(b); Ген Рat Streptomyces  viridochromogenes. Стандарты содержат правила и методы исследований испытаний) и измерений, в том числе правила отбора проб для однородных групп пищевого сырья (в том числе посевного и посадочного материала), пищевых продуктов, цветов.
118. How many laboratory personnel in your country have received training in detection of LMOs?
This question is relevant to indicator 2.3.1 of the Strategic Plan
  • One or more
119. Does your country have reliable access to laboratory facilities for the detection of LMOs?
This question is relevant to indicator 2.3.2 of the Strategic Plan
  • Yes
120. How many laboratories in your country are certified for LMO detection?
This question is relevant to indicator 2.3.3 of the Strategic Plan
  • One or more
121. How many of the certified laboratories in the previous question are currently operating in the detection of LMOs?
This question is relevant to indicator 2.3.4 of the Strategic Plan
  • One or more
122. Here you may provide further details on the implementation of Article 18 in your country:
RU
Осуществление статьи 18 частично регулируется Законом РК «О безопасности пищевой продукции» (2008), Кодексом РК «О здоровье населения и системе здравоохранения» (2009), Законом РК "О техническом регулировании" (2004), техническими регламентами «Требования к безопасности пищевой продукции, полученной из генно-модифицированных (трансгенных) растений и животных» (2010) и "Требования к упаковке, маркировке, этикетированию и правильному их нанесению (2004)", Техническим регламентом Таможенного союза «О безопасности пищевой продукции» (ТР ТС 021/2011) (2011), Правилами оборота генетически модифицированных объектов (2008), а также стандартами РК: СТ РК 1346-2005(Р 52173-2003, MOD) "Биологическая безопасность. Сырье и продукты пищевые. Метод идентификации генетически модифицированных источников (ГМИ) растительного происхождения, СТ РК 1345-2005 (Р 52174-2003, MOD) Биологическая безопасность. Сырье и продукты пищевые. Метод идентификации генетически модифицированных источников (ГМИ) растительного происхождения с применением биологического микрочипа.
Article 19 – Competent National Authorities and National Focal Points
123. In case your country has designated more than one competent national authority, has your country established a mechanism for the coordination of their actions prior to taking decisions regarding LMOs?
  • Not applicable
124. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • No
125. Here you may provide further details on the implementation of Article 19 in your country
RU
Постановлением Правительства РК №1282 от 26 декабря 2008 года Министерство сельского хозяйства РК назначено национальным координационным центром по Картахенскому протоколу по биобезопасности (КПБ), Министерство науки и образования РК - компетентным национальным органом.  Приказом Министерства образования и науки РК №579 от 20 декабря 2009 г. РГП «Национальный центр биотехнологии»  КН МОН РК определен контактным пунктом по реализации механизма посредничества в области биологической безопасности (Biosafety Clearing-House Focal Point).
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
126. Please provide an overview of the status of the mandatory information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
This question is relevant to indicator 3.1.5 of the Strategic Plan
a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available and in the BCH
b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information available and in the BCH
c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information available but only partially available in the BCH
d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available but only partially available in the BCH
e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available and in the BCH
f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information not available
j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
127. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • No
128. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes, to some extent
129. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • No
130. Has your country experienced difficulties accessing or using the BCH?
This question is relevant to indicator 4.1.8 of the Strategic Plan
  • No
131. Is the information submitted by your country to the BCH complete and up-to date?
  • Yes
132. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years:
This question is relevant to indicator 4.3.1 of the Strategic Plan
  • One or more
133. Please indicate the number of biosafety related publications that has been made available in your country in the last year:
This question is relevant to indicator 4.3.2 of the Strategic Plan
  • One or more
134. If biosafety related publications were made available (see question above), please indicate which modalities were preferred:
This question is relevant to indicator 4.3.2 of the Strategic Plan
  • National website
  • National Libraries
135. Here you may provide further details on the implementation of Article 20 in your country
RU
Обмен информацией осуществляется посредством веб-сайта Национального центра биотехнологии, являющегося Контактным пунктом Механизма посредничества по биобезопасности http://www.biocenter.kz, раздел "Картахенский протокол",веб-сайта журнала "Биотехнология. Теория и практика" http://www.biotechlink.kz, издаваемого Национальным центром биотехнологии, а также посредством рассылки в национальные научные, научно-технические и университетские библиотеки и профильные научные организации.
Article 21 – Confidential information
136. Has your country established procedures to protect confidential information received under the Protocol?
  • No
137. Does your country allow the notifier to identify information that is to be treated as confidential?
  • No
138. Here you may provide further details on the implementation of Article 21 in your country
RU
Вопросы по конфиденциальности информации предусмотрены в проекте Закона РК "О государственном регулировании генно-инженерной деятельности", находящегося на рассмотрении Мажилиса Парламента РК.
Article 22 – Capacity-building
139. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
This question is relevant to indicator 1.2.6 and 3.1.8 of the Strategic Plan
  • No
140. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes, to some extent
Here you may provide further details
RU
В рамках проекта ЮНЕП "Разработка национальных механизмов по обеспечению биобезопасности Республики Казахстан" при финансовой поддержке Глобального экологического фонда
141. If you answered Yes to question 140, how were these resources made available?
  • Regional channels
142. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • No
144. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
145. If you answered Yes to question 144, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 157.
  • Difficult
146. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Development of national biosafety frameworks
147. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes, to some extent
148. If you answered Yes to question 147, in which of the following areas were these activities undertaken?
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Scientific biosafety research relating to LMOs
149. During the current reporting period, has your country carried out a capacity-building needs assessment?
This question is relevant to indicator 1.2.1 of the Strategic Plan
  • No
151. Does your country still have capacity-building needs?
This question is relevant to indicator 1.2.7 of the Strategic Plan
  • Yes
152. If you answered Yes to question 151, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
153. Has your country developed a capacity-building strategy or action plan?
This question is relevant to indicator 1.2.2 of the Strategic Plan
  • No
154. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
This question is relevant to indicator 1.2.4 of the Strategic Plan
  • No
155. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
This question is relevant to indicator 1.2.3 of the Strategic Plan
  • None
156. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • No
157. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds
RU
Подготовлен проект "Укрепление потенциала для осуществления Картахенского протокола по биобезопасности в Казахстане", для целевого финансирования в рамках ГЭФ-6 по проритетному направлению "Биоразнообразие". Также планируется участие в региональном проекте "Создание потенциала для формирования сети лабораторий по детекции ГМО и создание единой референсной лаборатории стран СНГ", подготовленном Республикой Беларусь.
Article 23 – Public awareness and participation
158. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to some extent
Here you may provide further details
RU
Министерство энергетики Республики Казахстан в настоящее время проводит согласование поправки «О Генетически измененных организмах» к Конвенции о доступе к информации, участии общественности в процессе принятия решений и доступе к правосудию по вопросам, касающимся окружающей среды, внесенной в Перспективный план заключения международных договоров на 2016-2018 гг.
159. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
This question is relevant to indicator 5.3.2 of the Strategic Plan
  • No
160. Does your country have any awareness and outreach programmes on biosafety?
This question is relevant to indicator 5.3.1 of the Strategic Plan
  • No
161. If you answered Yes to question 160, please indicate what entity is responsible for carrying out the programmes and/or services and at which level the programmes take place (e.g. local, national, etc.):
This question is relevant to indicator 5.3.1 of the Strategic Plan
RU
Республика Казахстан ратифицировала Орхусскую конвенцию "О доступе к информации, участии общественности в процессе принятия решений и доступе к правосудию, касающемуся окружающей среды", http://www.aarhus.kz/
162. Has your country established a biosafety website searchable archives, national resource centres or sections in existing national libraries dedicated to biosafety educational materials?
This question is relevant to indicators 2.5.3 and 5.3.3 of the Strategic Plan
  • Yes
163. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
This question is relevant to indicator 5.2.1 of the Strategic Plan
  • None
164. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • Yes, to some extent
165. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
This question is relevant to indicator 2.5.1 of the Strategic Plan
  • Yes, to some extent
Here you may provide further details
RU
В соответствии с частью 3 статьи 57 Экологического кодекса РК, по проектам, намечаемой хозяйственной и иной деятельности, реализация которых может непосредственно повлиять на окружающую среду и здоровье граждан, проводятся общественные слушания.
166. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
This question is relevant to indicator 2.5.1 of the Strategic Plan
  • Yes, to some extent
Here you may provide further details
RU
В соответствии с частью 3 статьи 57 Экологического кодекса РК, по проектам, намечаемой хозяйственной и иной деятельности, реализация которых может непосредственно повлиять на окружающую среду и здоровье граждан, проводятся общественные слушания.
167. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
This question is relevant to indicator 2.5.2 of the Strategic Plan
  • Yes, to some extent
Here you may provide further details
RU
В соответствии с частью 3 статьи 57 Экологического кодекса РК, по проектам, намечаемой хозяйственной и иной деятельности, реализация которых может непосредственно повлиять на окружающую среду и здоровье граждан, проводятся общественные слушания.
168. If you answered Yes to question 167, please indicate the modalities used to inform the public:
This question is relevant to indicator 2.5.2 of the Strategic Plan
  • Public hearings
169. If you indicated more than one modality for public participation in question 168, which one was most used?
This question is relevant to indicator 2.5.2 of the Strategic Plan
  • Public hearings
170. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • No
171. How many academic institutions in your country are offering biosafety education and training courses and programmes?
This question is relevant to indicator 2.7.1 of the Strategic Plan
  • One or more
172. Please indicate the number of educational materials and/or online modules on biosafety that are available and accessible to the public in your country:
This question is relevant to indicators 2.7.2 and 5.3.4 of the Strategic Plan
  • One or more
173. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • No
175. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • Never
176. Here you may provide further details on the implementation of Article 23 in your country
RU
РК является стороной Орхусской конвенции и обеспечивает доступ к информации, участие общественности и доступ к правосудию в отношении генетически измененных организмов. Принято решение о ратификации поправки «О генетически измененных организмах» к Орхусской конвенции о доступе к информации, участии общественности в процессе принятия решений и доступе к правосудию по вопросам, касающимся окружающей среды. Ратификация данной поправки внесена в Перспективный план заключения международных договоров на 2016-2018 гг. В настоящий момент проводятся внутригосударственные процедуры. Кроме того, в Государственном фонде экологической информации имеются данные по биоразнообразию, которые представляются общественности на бесплатной основе в виде государственной услуги. Имеется доступ к информации по биобезопасности через веб-сайт Национального центра биотехнологии, являющегося Контактным пунктом Механизма посредничества по биобезопасности, http://www.biocenter.kz
Article 24 – Non-Parties
177. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • Yes
178. Has your country ever imported LMOs from a non-Party?
  • No
179. Has your country ever exported LMOs to a non-Party?
  • No
Article 25 – Illegal transboundary movements
184. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • Yes, to some extent
185. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • No
186. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
If you replied Never to question 186 please go to question 191
  • Never
Article 26 – Socio-economic considerations
192. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
This question is relevant to indicator 1.7.2 of the Strategic Plan
  • No
193. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Not applicable
194. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
This question is relevant to indicator 1.7.1 of the Strategic Plan
  • None
196. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
Article 27 – Liability and Redress
198. Has your country ratified or acceded to the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
199. If you answered No to question 198, is there any national process in place towards becoming a Party?
  • No
200. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
This question is relevant to indicator 2.4.1 of the Strategic Plan
  • No
201. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
This question is relevant to indicators 1.5.2 and 2.4.2 of the Strategic Plan
  • No
Article 28 – Financial Mechanism and Resources
203. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
This question is relevant to indicator 1.2.5 of the Strategic Plan
  • Not applicable
Article 33 – Monitoring and reporting
204. Does your country have in place a monitoring and/or an enforcement system for the implementation of the Cartagena Protocol?
This question is relevant to indicator 3.1.6 of the Strategic Plan
a) Monitoring system:
  • No
b) Enforcement system:
  • No
205. Has your country submitted all the previous due National Reports?
  • Yes